Global Octreotide Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Octreotide Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically,it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

According to APO Research, The global Octreotide market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Octreotide include Novartis, Sun Pharmaceutical, Chengdu Tiantaishan pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals and Yibin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Octreotide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Octreotide, also provides the sales of main regions and countries. Of the upcoming market potential for Octreotide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Octreotide sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Octreotide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Octreotide sales, projected growth trends, production technology, application and end-user industry.

Octreotide segment by Company

Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Octreotide segment by Type

Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Octreotide segment by Application

Treating Severe Diarrhea
Treating Acromegaly
Others
Octreotide segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Octreotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Octreotide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Octreotide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Octreotide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Octreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Octreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Octreotide Market Size, 2019 VS 2023 VS 2030
1.3 Global Octreotide Market Size Estimates and Forecasts (2019-2030)
1.4 Global Octreotide Sales Estimates and Forecasts (2019-2030)
1.5 Global Octreotide Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Octreotide Market Dynamics
2.1 Octreotide Industry Trends
2.2 Octreotide Industry Drivers
2.3 Octreotide Industry Opportunities and Challenges
2.4 Octreotide Industry Restraints
3 Octreotide Market by Manufacturers
3.1 Global Octreotide Revenue by Manufacturers (2019-2024)
3.2 Global Octreotide Sales by Manufacturers (2019-2024)
3.3 Global Octreotide Average Sales Price by Manufacturers (2019-2024)
3.4 Global Octreotide Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Octreotide Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Octreotide Manufacturers, Product Type & Application
3.7 Global Octreotide Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Octreotide Market CR5 and HHI
3.8.2 Global Top 5 and 10 Octreotide Players Market Share by Revenue in 2023
3.8.3 2023 Octreotide Tier 1, Tier 2, and Tier 3
4 Octreotide Market by Type
4.1 Octreotide Type Introduction
4.1.1 Octreotide Injection
4.1.2 Octreotide Powder
4.1.3 Octreotide Microspheres
4.2 Global Octreotide Sales by Type
4.2.1 Global Octreotide Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Octreotide Sales by Type (2019-2030)
4.2.3 Global Octreotide Sales Market Share by Type (2019-2030)
4.3 Global Octreotide Revenue by Type
4.3.1 Global Octreotide Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Octreotide Revenue by Type (2019-2030)
4.3.3 Global Octreotide Revenue Market Share by Type (2019-2030)
5 Octreotide Market by Application
5.1 Octreotide Application Introduction
5.1.1 Treating Severe Diarrhea
5.1.2 Treating Acromegaly
5.1.3 Others
5.2 Global Octreotide Sales by Application
5.2.1 Global Octreotide Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Octreotide Sales by Application (2019-2030)
5.2.3 Global Octreotide Sales Market Share by Application (2019-2030)
5.3 Global Octreotide Revenue by Application
5.3.1 Global Octreotide Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Octreotide Revenue by Application (2019-2030)
5.3.3 Global Octreotide Revenue Market Share by Application (2019-2030)
6 Global Octreotide Sales by Region
6.1 Global Octreotide Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Octreotide Sales by Region (2019-2030)
6.2.1 Global Octreotide Sales by Region (2019-2024)
6.2.2 Global Octreotide Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Octreotide Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Octreotide Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Octreotide Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Octreotide Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Octreotide Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Octreotide Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Octreotide Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Octreotide Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Octreotide Revenue by Region
7.1 Global Octreotide Revenue by Region
7.1.1 Global Octreotide Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Octreotide Revenue by Region (2019-2024)
7.1.3 Global Octreotide Revenue by Region (2025-2030)
7.1.4 Global Octreotide Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Octreotide Revenue (2019-2030)
7.2.2 North America Octreotide Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Octreotide Revenue (2019-2030)
7.3.2 Europe Octreotide Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Octreotide Revenue (2019-2030)
7.4.2 Asia-Pacific Octreotide Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Octreotide Revenue (2019-2030)
7.5.2 LAMEA Octreotide Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Novartis
8.1.1 Novartis Comapny Information
8.1.2 Novartis Business Overview
8.1.3 Novartis Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Novartis Octreotide Product Portfolio
8.1.5 Novartis Recent Developments
8.2 Sun Pharmaceutical
8.2.1 Sun Pharmaceutical Comapny Information
8.2.2 Sun Pharmaceutical Business Overview
8.2.3 Sun Pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Sun Pharmaceutical Octreotide Product Portfolio
8.2.5 Sun Pharmaceutical Recent Developments
8.3 Chengdu Tiantaishan pharmaceutical
8.3.1 Chengdu Tiantaishan pharmaceutical Comapny Information
8.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
8.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
8.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
8.4 Sinopharm A-Think Pharmaceuticals
8.4.1 Sinopharm A-Think Pharmaceuticals Comapny Information
8.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
8.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
8.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
8.5 Sihuan Pharmaceutical Holdings Group
8.5.1 Sihuan Pharmaceutical Holdings Group Comapny Information
8.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
8.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
8.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
8.6 Shanghai Soho-Yiming Pharmaceuticals
8.6.1 Shanghai Soho-Yiming Pharmaceuticals Comapny Information
8.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
8.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
8.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
8.7 Yibin Pharmaceutical
8.7.1 Yibin Pharmaceutical Comapny Information
8.7.2 Yibin Pharmaceutical Business Overview
8.7.3 Yibin Pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
8.7.5 Yibin Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Octreotide Value Chain Analysis
9.1.1 Octreotide Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Octreotide Production Mode & Process
9.2 Octreotide Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Octreotide Distributors
9.2.3 Octreotide Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings